Literature DB >> 26187467

Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.

Vinayak Vittal1, Mikaela D Stewart1, Peter S Brzovic1, Rachel E Klevit2.   

Abstract

Since its discovery as a post-translational signal for protein degradation, our understanding of ubiquitin (Ub) has vastly evolved. Today, we recognize that the role of Ub signaling is expansive and encompasses diverse processes including cell division, the DNA damage response, cellular immune signaling, and even organismal development. With such a wide range of functions comes a wide range of regulatory mechanisms that control the activity of the ubiquitylation machinery. Ub attachment to substrates occurs through the sequential action of three classes of enzymes, E1s, E2s, and E3s. In humans, there are 2 E1s, ∼ 35 E2s, and hundreds of E3s that work to attach Ub to thousands of cellular substrates. Regulation of ubiquitylation can occur at each stage of the stepwise Ub transfer process, and substrates can also impact their own modification. Recent studies have revealed elegant mechanisms that have evolved to control the activity of the enzymes involved. In this minireview, we highlight recent discoveries that define some of the various mechanisms by which the activities of E3-Ub ligases are regulated.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E3 ubiquitin ligase; HECT; RING; cullin; parkin; ubiquitin; ubiquitin ligase; ubiquitin regulation; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2015        PMID: 26187467      PMCID: PMC4571856          DOI: 10.1074/jbc.R115.675165

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  An mRNA surveillance mechanism that eliminates transcripts lacking termination codons.

Authors:  Pamela A Frischmeyer; Ambro van Hoof; Kathryn O'Donnell; Anthony L Guerrerio; Roy Parker; Harry C Dietz
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

Review 2.  The evolution of thalidomide and its IMiD derivatives as anticancer agents.

Authors:  J Blake Bartlett; Keith Dredge; Angus G Dalgleish
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

3.  Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination.

Authors:  Zhizhi Wang; Gregory A Michaud; Zhihong Cheng; Yue Zhang; Thomas R Hinds; Erkang Fan; Feng Cong; Wenqing Xu
Journal:  Genes Dev       Date:  2012-01-19       Impact factor: 11.361

4.  A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation.

Authors:  Joseph J Higgins; Joanna Pucilowska; Roni Q Lombardi; John P Rooney
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

5.  Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.

Authors:  Noam Levaot; Oleksandr Voytyuk; Ioannis Dimitriou; Fabrice Sircoulomb; Arun Chandrakumar; Marcel Deckert; Paul M Krzyzanowski; Andrew Scotter; Shengqing Gu; Salima Janmohamed; Feng Cong; Paul D Simoncic; Yasuyoshi Ueki; Jose La Rose; Robert Rottapel
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

6.  Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products.

Authors:  Quentin Defenouillère; Yanhua Yao; John Mouaikel; Abdelkader Namane; Aurélie Galopier; Laurence Decourty; Antonia Doyen; Christophe Malabat; Cosmin Saveanu; Alain Jacquier; Micheline Fromont-Racine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

7.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes.

Authors:  Ian R Kelsall; David M Duda; Jennifer L Olszewski; Kay Hofmann; Axel Knebel; Frédéric Langevin; Nicola Wood; Melanie Wightman; Brenda A Schulman; Arno F Alpi
Journal:  EMBO J       Date:  2013-09-27       Impact factor: 11.598

9.  Structure and assembly pathway of the ribosome quality control complex.

Authors:  Sichen Shao; Alan Brown; Balaji Santhanam; Ramanujan S Hegde
Journal:  Mol Cell       Date:  2015-01-08       Impact factor: 17.970

10.  Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism.

Authors:  David M Duda; Jennifer L Olszewski; Jonathan P Schuermann; Igor Kurinov; Darcie J Miller; Amanda Nourse; Arno F Alpi; Brenda A Schulman
Journal:  Structure       Date:  2013-05-23       Impact factor: 5.006

View more
  44 in total

1.  RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Authors:  Tomohiro Watanabe; Kosuke Minaga; Ken Kamata; Toshiharu Sakurai; Yoriaki Komeda; Tomoyuki Nagai; Atsushi Kitani; Masaki Tajima; Ivan J Fuss; Masatoshi Kudo; Warren Strober
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

2.  CUL4B promotes the pathology of adjuvant-induced arthritis in rats through the canonical Wnt signaling.

Authors:  Chenggui Miao; Jun Chang; Guoxue Zhang; Hao Yu; Lili Zhou; Guoliang Zhou; Chuanlei Zhao
Journal:  J Mol Med (Berl)       Date:  2018-04-06       Impact factor: 4.599

3.  Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.

Authors:  Fiorenza Fumagalli; Julia Noack; Timothy J Bergmann; Eduardo Cebollero; Giorgia Brambilla Pisoni; Elisa Fasana; Ilaria Fregno; Carmela Galli; Marisa Loi; Tatiana Soldà; Rocco D'Antuono; Andrea Raimondi; Martin Jung; Armin Melnyk; Stefan Schorr; Anne Schreiber; Luca Simonelli; Luca Varani; Caroline Wilson-Zbinden; Oliver Zerbe; Kay Hofmann; Matthias Peter; Manfredo Quadroni; Richard Zimmermann; Maurizio Molinari
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

Review 4.  N-degron and C-degron pathways of protein degradation.

Authors:  Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

5.  Five enzymes of the Arg/N-degron pathway form a targeting complex: The concept of superchanneling.

Authors:  Jang-Hyun Oh; Ju-Yeon Hyun; Shun-Jia Chen; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

6.  It's all about talking: two-way communication between proteasomal and lysosomal degradation pathways via ubiquitin.

Authors:  Martina P Liebl; Thorsten Hoppe
Journal:  Am J Physiol Cell Physiol       Date:  2016-05-25       Impact factor: 4.249

Review 7.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

8.  A reference-based protein degradation assay without global translation inhibitors.

Authors:  Jang-Hyun Oh; Shun-Jia Chen; Alexander Varshavsky
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

9.  The Arg/N-degron pathway targets transcription factors and regulates specific genes.

Authors:  Tri T M Vu; Dylan C Mitchell; Steven P Gygi; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

10.  The Arabidopsis ALF4 protein is a regulator of SCF E3 ligases.

Authors:  Rammyani Bagchi; Charles W Melnyk; Gideon Christ; Martin Winkler; Kerstin Kirchsteiner; Mohammad Salehin; Julia Mergner; Michael Niemeyer; Claus Schwechheimer; Luz Irina A Calderón Villalobos; Mark Estelle
Journal:  EMBO J       Date:  2017-12-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.